Indivior INDV 深 滬
等待開盤 10-08 09:30:00 美东时间
36.13
+0.230
+0.64%
華盛通- 最 高36.295
- 今 開35.58
- 成交量 176.96万股
- 最 低 35.58
- 昨 收 35.90
- 總市值 42.64亿
- 52周最高 42.81
- 市盈率 靜 22.02
- 換手率 1.50%
- 52周最低 23.72
- 委 比 29.87%
- 總股本 1.18亿
- 歷史最高 42.81
- 量 比 0.83
- 振 幅 1.99%
- 歷史最低 7.33
- 每 手 1
- 風險率 4.14%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Addex Therapeutics shares are trading higher after the company announced it regained full global rights to all GABAB positive allosteric modulator assets discovered under its research collaboration with Indivior UK.
Addex Therapeutics shares are trading higher after the company announced it regained full global rights to all GABAB positive allosteric modulator assets discovered under its research collaboration with Indivior UK.
09-25 20:28
Indivior declares $8.13 dividend
Indivior (INDV) declares $8.13/share special dividend. Payable Nov. 6; for shareholders of record Oct. 30; ex-div Oct. 30. See INDV Dividend Scorecard, Yield Chart, & Dividend Growth. More on Indivior...
09-17 19:52
Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend
Indivior Pharmaceuticals announced a special cash dividend of $8.13 per share, contingent on the completion of its merger with Supernus Pharmaceuticals by November 2, 2026. The dividend will be paid to eligible shareholders on November 6, 2026, if the merger closes as expected. Supernus shareholders will not receive the dividend for any Indivior shares they acquire in the merger.
09-17 11:00
朝阳门并购堂 | 2026年8月并购重组市场观察
（来源：中信建投证券投行委） 一、新增重组事件 （一）有研硅(688432.SH)停牌筹划重组 （二）雪天盐业(600929.SH) 停牌筹划重组 ...
09-16 17:09
美股大行评级 | AMD、Arista Networks、Booking 、加特纳、Pinterest、科力斯、Wayfair等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Precigen"买入"评级，目标价从14美元升至18美元；HC Wainwright & Co.：维持Sophia Genetics"买入"评级，目标价从12美元升至14美元
08-06 11:36
财报速睇 | Indivior Pharmaceuticals, Inc. 2026财年Q2营收3.43亿美元，同比增长13.6%；归母净利润1.22亿美元，同比增长577.8%
华盛资讯8月4日讯，Indivior Pharmaceuticals, Inc.公布2026财年Q2业绩，公司Q2营收3.43亿美元，同比增长13.6%，归母净利润1.22亿美元，同比增长577.8%。
08-04 05:36
财报速睇 | Indivior Pharmaceuticals, Inc. 2026财年Q2营收3.43亿美元，同比增长13.6%；归母净利润1.22亿美元，同比增长577.8%
华盛资讯8月4日讯，Indivior Pharmaceuticals, Inc.公布2026财年Q2业绩，公司Q2营收3.43亿美元，同比增长13.6%，归母净利润1.22亿美元，同比增长577.8%。
08-04 04:02
Indivior Pharmaceuticals Raises FY2026 Sales Guidance from $1.215B-$1.285B to $1.295B-$1.365B vs $1.245B Est
Indivior Pharmaceuticals (NASDAQ:INDV) raises FY2026 sales outlook from $1.215 billion-$1.285 billion to $1.295 billion-$1.365 billion vs $1.245 billion estimate.
08-03 18:45
Supernus Pharmaceuticals To Merge With Indivior Pharmaceuticals; SUPN Stockholders Will Receive 1.5401 Shares Of INDV Per SUPN Share; Indivior Stockholders Will Receive One-Time Special Cash Dividend Of $1B Immediately Prior To Closing; Expected To Generate $125M In Annual Cost Synergies
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) and Indivior Pharmaceuticals, Inc. (NASDAQ:INDV) today announced that they have entered into a definitive agreement to combine in a tax-free all-stock merger of equals transaction to create a leading diversified, central nervous system (CNS) biopharmaceut...
08-03 18:35
美股夜盘 | Bloom Energy涨8.37%，Intuitive Machines涨5.47%
Bloom Energy涨8.37%；Intuitive Machines涨5.47%；万国数据涨3.23%
07-01 15:01
